Delivra Health Brands Inc. saw a significant drop in its stock price following a week of gains.
Delivra Health Brands Inc. (DHB.V) has experienced notable volatility this week, culminating in an 8% decline in its stock price on Thursday. This follows a substantial rise of over 35% in the preceding week, showcasing the stock's unpredictable nature. With a market cap of approximately C$3.6 million, the company continues to navigate a challenging landscape in the health care sector.
Investor takeaway: Investors should be aware of the recent price fluctuations and consider the company's product launches and financial performance when evaluating Delivra Health Brands.
Advertisement
Delivra Health Brands Inc.
DHB.V
DHB.V
Delivra Health Brands Inc.
WealthAwesomeMarket cap
$3.60M
52W high
$0.37
52W low
$0.08
1W change
+35.29%
Beta
0.86
Analyst Price Targets
Based on analyst covering DHB
Wall Street analysts forecast DHB stock price to rise 360.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.53
+360.9% Upside
Current Price
C$0.12
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on DHB's historical volatility
30-Day Vol
168.4%
Annualized
90-Day Vol
127.1%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.10
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.11 | C$0.06 – C$0.19 |
| 60 trading days | C$0.10 | C$0.04 – C$0.23 |
| 90 trading days | C$0.10 | C$0.04 – C$0.26 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Delivra Health Brands Inc. stock falls 8% on Thursday.
The stock's performance remains volatile, with a year-to-date decline of 42.5%, highlighting the challenges faced by the company.
Bull case
Delivra's recent product launches, including LivRelief™ Itch Relief Cream and Dream Water® Kids Sleep Gummies, could boost future growth and attract consumer interest, especially in a competitive health care market.
Bear case
Despite recent gains, the company's negative profit margin and declining year-to-date performance may raise concerns among investors about its long-term viability.
Recent Price Action
Delivra Health Brands Inc. closed at C$0.12 on Thursday, reflecting an 8% decrease from the previous day. This drop comes after a remarkable week where the stock surged by 35.29%. Over the past month, the stock has gained 27.78%, although it remains down 42.50% year-to-date.
Catalysts and Company News
Advertisement
Despite no new major announcements this week, Delivra Health has recently been active in expanding its product offerings. The launch of LivRelief™ Itch Relief Cream in Canada and Dream Water® Kids Sleep Gummies in the U.S. indicates the company's efforts to capture a larger market share. These product launches may have contributed to the stock's earlier gains this week.
Technical Picture
From a technical standpoint, Delivra Health's current price of C$0.12 is above its 50-day moving average of C$0.10, suggesting a short-term bullish trend. However, it remains below the 200-day moving average of C$0.16, indicating potential long-term weakness. The stock has traded within a 52-week range of C$0.08 to C$0.37, with the current price at approximately 14% of this range. With a beta of 0.86, the stock has shown less volatility compared to the overall market.
Volume Analysis
The latest trading volume for Delivra Health was 50,000 shares, which is 1.77 times higher than the 20-day average volume of 43,121 shares. This increase in volume may suggest heightened investor interest, possibly in response to the recent product launches and the stock's volatility.
Price Action Summary
As of the last close, Delivra Health Brands Inc. stock is priced at C$0.12, reflecting an 8% decline for the day. Investors should monitor upcoming developments and product launches for further insights into the company's performance.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
